Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads In Hematologic Malignancies

Hematologic Malignancies for September/October 2018

Long-term ibrutinib data in older patients, Barr PM et al. Haematologica. 2018;103(9):1502-10

More must reads

Hematologic Malignancies for November/December 2017

Prognostic Score System for Patients with PMF, J Clin Oncol; ePub 2017 Dec 9; Gugliemelli, et al

These Patients Are More Apt to Be Depressed, Ann Hematol; ePub 2017 Dec 7; Shreders, et al

Survival Length Shortest in These Patients with MF, Eur J Haematol; ePub 2017 Dec 11; Masarova, et al

The Value of Ruxolitinib Before and After AlloSCT, Blood; ePub 2017 Dec 7; Poulose, Malysz, et al

Tyrosine Kinase Inhibitors in Pediatric ALL, Hematology 2017; 2017 Dec 8; Silverman, et al

More must reads

Hematologic Malignancies for September/October 2017

NCCN Guideline Adherence Spotty in These Patients, Am J Hematol; ePub 2017 Aug 17; Goldberg, et al

Economic Burden of Auto- and Allo-HCT Evaluated, J Med Econ; ePub 2017 Aug 24; Bonafede, et al

Assessing End-of-Life Treatment in Young People, J Oncol Pract; ePub 2017 Aug 22; Johnston, et al

Look for This in Patients with ECD, Histiocytosis, Blood; 2017 Aug 24; Papo, Diamond, et al

Targeted Next-Generation Sequencing in MDS, Am J Hematol; ePub 2017 Sep 5; Tefferi, et al

More must reads

Hematologic Malignancies for July/August 2017

MF Treatment Pre- and Post Ruxolitinib Approval, Clin Lymphoma Myeloma Leuk; 2017 Aug 4; Kuykendall, et al

CML-BP Outcomes in Tyrosine Kinase Inhibitor Era , Cancer; ePub 2017 Jul 25; Jain, Kantarjian, et al

Predicting Survival in Patients with Post-PV/ET, Leukemia; ePub 2017 Aug 18; Tefferi, Saeed, et al

Ruxolitinib’s Role in Ph-Like ALL , Clin Adv Hematol Oncol; 2017 Jul; Wells, et al

Building on Ruxolitinib’s Success , Clin Lymphoma Myeloma Leuk; 2017 Jul; Bose, et al

More must reads

Hematologic Malignancies for May/June 2017

The Challenges of MPN Diagnosis and Risk Assessment, N Engl J Med; 2017 Jun 1; Spivak

How Post PPV and ET Differ from Primary Myelofibrosis , Leuk Res; 2017 Jun 2; Masarova, Bose, Daver et al

Timing of Antibiotic Administration for Neutropenic Fever, J Oncol Pharm Pract; 2017 Jun; Butts, et al

Tyrosine Kinase Inhibitors in Patients with AML, Stem Cell Investig; 2017 Jun 2; Chen, Pan, et al

Online Yoga Intervention in MPN Patients Evaluated, Haematologica; ePub 2017 Jun 8; Huberty, et al

More must reads

Pages